Overweight
Overweight is characterized by having a body mass index (BMI) of 25 to 29.9 and is defined as having more body fat than is optimally healthy. It is associated with an increased risk of conditions such as cardiovascular disease, particularly in sedentary lifestyles and environments with abundant food supplies, but this may not apply to individuals with higher lean mass, such as athletes or weight lifters.
Health Outcomes
- Atherogenic Lipid Profile
- Changed Anthropometric Measure
- Changed Body Mass Index
- Characterized Carbohydrate Metabolism Enzyme Activity
- Decreased HDL Cholesterol Level
- Distinct Metabolic Profile
- Enhanced Fat Oxidation
- Improved 5000 m Running Time
- Improved Adipocyte Inflammatory Profile
- Improved Adipokine Profile
- Improved Anthropometric Index
- Improved Anthropometric Measures
- Improved Atherosclerosis-Related Cardiovascular Risk Markers
- Improved Athletic Performance
- Improved Bioactivity
- Improved Blood Glucose Control
- Improved Body Composition
- Improved Body Mass Index
- Improved Body Weight
- Improved Cardiometabolic Score
- Improved Cycling Time Trial Performance
- Improved Diet
- Improved Eating Behaviors
- Improved Gastroesophageal Reflux Symptoms
- Improved Gastrointestinal Hormone Regulation
- Improved Maternal Metabolic Health
- Improved Metabolic Homeostasis
- Improved Metabolic Syndrome Remission
- Improved Nutritional Quality
- Improved Running Economy
- Improved Running Endurance
- Improved Running Performance
- Improved Satiety
- Improved Satiety Hormonal Status
- Improved Satiety Index
- Improved Satiety Response
- Improved Satiety Score
- Improved Swimming Performance
- Improved Systemic Health
- Improved Thermotolerance
- Improved Time-Trial Performance
- Improved VLDL Cholesterol
- Improved Vertical Jump Performance
- Improved Weight Control
- Improved Weight Loss
- Improved Yo-Yo Test Performance
- Increased Acyl/Des-Acyl Ghrelin Ratio
- Increased Adipogenesis
- Increased Adipose Browning
- Increased Appendicular Skeletal Muscle Mass Index
- Increased Birth Length
- Increased Birth Weight
- Increased Birthweight
- Increased Body Weight
- Increased Daily Weight Gain
- Increased Fecal Lipid Excretion
- Increased GLP-1 Levels
- Increased Gestational Age at Delivery
- Increased Growth Rate
- Increased Infant Birthweight
- Increased Infant Weight
- Increased Insulin Secretion
- Increased Lower Body Weight
- Increased Maternal Weight Gain During Pregnancy
- Increased Neonatal Birth Length
- Increased Newborn Weight
- Increased Resistant Starch
- Increased Serum Insulin Level
- Increased Thermogenic Adipocyte Activity
- Increased Weight
- Increased Weight Gain
- Increased Weight Velocity
- Increased Weight Z-Score in Infants
- Increased Weight in Normal Weight Children
- Increased Weight of Ham
- Induced Type 2 Diabetes Remission
- Influence on Infant Weight
- Maintained Body Weight
- Maintained Normal Weight
- Multiple Health-Promoting Effects
- No Change in Body Weight or Cardiometabolic Parameters
- No Change in Body Weight or Food Consumption
- No Change in Metabolic Health
- No Change in Microbial Diversity
- No Increase in Plasma Endotoxin
- No Significant Change in Body Weight or Systemic Inflammation
- No Significant Change in Endocannabinoid or Inflammatory Biomarkers
- No Significant Change in Lean Body Mass
- No Significant Change in Muscle Mass
- Prevented Type 2 Diabetes
- Prevention of Obesity Transition
- Prevention of Weight Gain
- Promoted Weight Gain
- Reduced Adipocyte Senescence
- Reduced Adiposity
- Reduced Atherosclerosis Risk Factors
- Reduced Blood Glucose Elevation
- Reduced Breast Cancer Risk
- Reduced Cardiovascular Disease Risk
- Reduced Cardiovascular Risk
- Reduced Diabetes Incidence
- Reduced Fat Gain
- Reduced Food Cravings
- Reduced GIP
- Reduced Gestational Diabetes
- Reduced Incidence of Type 2 Diabetes
- Reduced Leg Adiposity
- Reduced Metabolic Disease Risk
- Reduced Metabolic Dysregulation
- Reduced Metabolic Syndrome Prevalence
- Reduced Metabolic Syndrome Risk
- Reduced N-terminal Pro-brain Natriuretic Peptide Level
- Reduced Non-Communicable Disease Risk
- Reduced Obesity
- Reduced Osteoporosis
- Reduced Pancreatic Stress-Related Pathways
- Reduced Post-Exercise Energy Intake
- Reduced Post-Exercise Serum Amyloid A Increase
- Reduced Postprandial Blood Glucose
- Reduced Postprandial GLP-1 Level
- Reduced Postprandial Glycemic Response
- Reduced Postprandial Triacylglycerol Response
- Reduced Pro-brain Natriuretic Peptide Level
- Reduced Progression to Hypertension
- Reduced Recovery Time After Surgery
- Reduced Risk of Coronary Heart Disease
- Reduced Risk of Preeclampsia
- Reduced Risk of Type 2 Diabetes
- Reduced Sugar-Sweetened Beverage Intake
- Reduced Systemic Endotoxemia at Rest
- Reduced Type II Diabetes Mellitus Incidence
- Reduced Ultraprocessed Food Consumption
- Remission of Metabolic Syndrome
- Stable Appetite Parameters
- Stable Body Weight
- Stable Body-Mass Index (BMI)
- Stable Weight